Delivery Order SPE2DB24D2213-SPE2DB25FGWVM
- Not listed
- The Defense Logistics Agency awarded a $6,752.85 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed price contract has a completion date of September 4, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $28,274.55 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5 mL) with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a continuation of AmerisourceBergen's role as a critical federal medical procurement vendor, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $26,253.17 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed price contract. The order was competitively awarded without set-aside provisions and is scheduled for completion by May 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $21,873.55 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL). This competitively awarded, firm fixed-price delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract represents a routine pharmaceutical procurement executed through AmerisourceBergen's established supply chain relationship with the federal government. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,703.93 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5ML) with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,633.77 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 Syringe 0.5mL, a pneumococcal vaccine, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $67,149.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 Syringes (10-count). This competitively awarded delivery order, issued on August 25, 2025, carries an ultimate completion date of September 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December...
- The Defense Logistics Agency awarded a $3,267.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on May 8, 2025, with an ultimate completion date of May 9, 2025. The award, which was not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $86,365.07 delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract type. The award, announced on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this medical supply delivery order, which will be performed at the...
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- SPE2DB24D2213Indefinite Delivery Contract
- SPE2DB24D2213-SPE2DB25FGWVMDelivery Order
The Defense Logistics Agency awarded a $71,304.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with an ultimate completion date of June 4, 2025. This non-set-aside competitive award leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary operations. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling supply of a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to military healthcare systems worldwide. AmerisourceBergen's award reflects its established position as a critical vendor within the Defense Health Agency's medical supply chain, demonstrating its capability to compete successfully for federal pharmaceutical procurement requirements on behalf of military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $71.3k | 6/3/25 |